Results 1 - 6 of 6
1
[PROJECT] PROLIFICA - Prevention of Liver Fibrosis and Cancer in Africa
ID: 265994
Start date: 2011-02-01, End date: 2016-01-31
Chronic hepatitis B virus (HBV) infection affects 350 million people worldwide and 25-30% of these individuals will die as a result of their infection mainly as a results of hepatocellular carcinoma HCC. Liver cirrhosis, high viral load and dietary exposure to aflatoxin are r...
Programme: FP7-HEALTH
Record Number: 98355
Last updated on: 2017-05-26
ID: IC18970236
Start date: 1997-11-01, End date: 2001-04-30
To evaluate the role of T cell-associated lytic mechanisms in the killing of intracellular mycobacteria, and the contribution of these effector pathways to immunity against tuberculosis and leprosy.
Programme: FP4-INCO
Record Number: 39052
Last updated on: 2001-12-07
[PROJECT] Maternal mortality and obstetric care in longitudinal population-based studies in West Africa
ID: IC18970248
Start date: 1998-01-01, End date: 1999-12-31
The general objective of this proposal is to promote interventions to reduce maternal mortality and serious maternal morbidity in different West African settings. Based on a situation analysis using a multidisciplinary approach, possible interventions will be designed in conce...
Programme: FP4-INCO
Record Number: 40186
Last updated on: 2001-12-07
ID: IC18950011
Start date: 1996-01-01, End date: 2001-06-30
The general objectives are:
* To reduce childhood mortality in developing countries through better control of measles infection by developing a better immunization strategy.
* To investigate the hypothesis that standard titre measles immunization is associated with non-target...
Programme: FP4-INCO
Record Number: 31175
Last updated on: 2001-12-07
ID: IC18980375
Start date: 1999-01-01, End date: 2002-06-30
Programme: FP4-INCO
Record Number: 47335
Last updated on: 1999-04-20
[PROJECT] AFTBVAC - Development of a TB vaccine in Africa
ID: QLK2-CT-2002-01613
Start date: 2002-12-01, End date: 2006-05-31
Despite the millions of deaths from tuberculosis each year and the threat of increased drug resistance, tuberculosis vaccine development has been hugely under-resourced. We set out here to evaluate the safety and immunogenicity of new subunit Constructs in Africa, a continent ...
Programme: FP5-LIFE QUALITY
Record Number: 67118
Last updated on: 2006-06-13
1
List retrieved on: 2017-08-02
